Dysferlinopathy Protein in Peripheral Blood Monocytes.

CompletedOBSERVATIONAL
Enrollment

149

Participants

Timeline

Start Date

February 1, 2012

Primary Completion Date

February 27, 2012

Study Completion Date

July 17, 2017

Conditions
Muscular DystrophiesLimb-Girdle Muscular Dystrophy Type 2BMiyoshi MyopathyDistal Myopathy With Anterior Tibial Onset
Interventions
DIAGNOSTIC_TEST

Protein analysis

The investigator enrolled 149 healthy volunteers and collected peripheral blood samples for protein analysis. While 18 of these individuals with protein levels in the range of 40%-64% were predicted to be carriers by the monocyte assay, subsequent DYSF sequencing analysis in 14 of 18 detected missense variants in only four. Analysis of DNA methylation patterns at the DYSF locus showed no changes in methylation levels at CpG islands and shores between samples.

Trial Locations (1)

08041

Eduard Gallardo Vigo, Barcelona

All Listed Sponsors
lead

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

NCT06507215 - Dysferlinopathy Protein in Peripheral Blood Monocytes. | Biotech Hunter | Biotech Hunter